Christina Jenkins, MD
Colon & Rectal Surgery · Mission Viejo, CANPI 1881035814
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Medtronic at 25.3% of the total. Reporting peaked in 2022 at $2,046 and has fallen 68.3% since, to $650 in 2025.
Across 300 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$792
- Johnson & Johnson$645
- Axonics, Inc.$531
- Takeda Pharmaceuticals U.S.A., Inc.$475
- AbbVie$411
- plus $3K from 27 others
What the payments were for
- Travel & lodging$160%
- Food & beverage$7,07899%
- Gifts$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $1,809 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 52 | $792 |
| Johnson & Johnson | 26 | $645 |
| Axonics, Inc. | 11 | $531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $475 |
| AbbVie | 21 | $411 |
| Regeneron Healthcare Solutions, Inc. | 13 | $300 |
| Galderma Laboratories, L.p. | 13 | $260 |
| Sanofi | 9 | $252 |
| Braintree Laboratories, Inc. | 6 | $175 |
| Lilly USA, LLC | 7 | $163 |
| Daiichi Sankyo Inc. | 8 | $153 |
| Nestle Healthcare Nutrition Inc. | 8 | $153 |
| Alfasigma USA, Inc. | 7 | $127 |
| Bristol Myers Squibb | 6 | $112 |
| Vivus LLC | 5 | $107 |
| Redhill Biopharma Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Merck | 3 | $64 |
| Ferring Pharmaceuticals Inc. | 3 | $61 |
| QOL Medical, LLC | 2 | $57 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| Exact Sciences | 2 | $55 |
| Ionis Pharmaceuticals, Inc. | 2 | $46 |
| Intra-sana Laboratories | 1 | $41 |
| Ironwood Pharmaceuticals, Inc | 1 | $30 |
| Celltrion USA Inc. | 1 | $28 |
| Shire North American Group Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Baudax Bio Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,166 in reported general payments places this provider in the 60th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other colon & rectal surgery in Mission Viejo
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Joseph CarmichaelOrange$99K
- Phillip FleshnerWest Hollywood$95K
- Zuri MurrellBeverly Hills$86K
- Lorenc MalellariBakersfield$78K
- Ankit SarinSacramento$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.